Department of Orthopaedic Surgery, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore
Mini Review
Overcoming Clinical and Regulatory Hurdles in Mesodermal Stem Cell Therapy
Author(s): Azura Crencia*
Clinical trials in mesodermal stem cell therapy encounter hurdles such as establishing standardized protocols, ensuring patient safety, and
demonstrating long-term efficacy. Additionally, the regulatory environment is fraught with difficulties, including navigating evolving guidelines,
securing approval for novel therapies, and addressing ethical concerns. These factors collectively impact the pace at which promising therapies
can be validated and made available to patients. Mesodermal Stem Cell (MSC) therapy holds promise for treating various diseases due to their
immune modulatory and regenerative properties. However, its clinical translation faces significant regulatory challenges. This abstract explores
the current landscape of clinical trials involving MSC therapy, highlighting regulatory hurdles such as standardization of protocols, safety concerns
and et.. Read More»
DOI:
10.37421/2684-494X.2024.9.241
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 